Haemonetics Fiscal Q2 Adjusted Earnings, Revenue Rise

07:00 AM EST, 11/05/2026 (MT Newswires) -- Haemonetics (HAE) reported fiscal Q2 adjusted earnings Thursday of $1.35 per diluted share, up from $1.27 a year earlier. Analysts polled by FactSet expected $1.10. Revenue for the quarter ended Sept. 26 was $357.8 million, compared with $327.3 million a year earlier. Analysts expected $345.1 million. For fiscal 2027, the company expects 8% to 11% growth, compared with its prior growth guidance of 5% to 8%. Analysts are looking for $1.42 billion.